Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. | 131,000 | reported | 04 Jun 2020 | tx 16+332,009 |
| ONYX PHARMACEUTICALS INC | 77,756 | reported | 25 Jul 2012 | tx 12+279,150−10,209 |
| Savara Inc | 62,451 | reported | 19 Jun 2013 | tx 3+95,517 |
| Royalty Pharma plc | 53,848 | reported | 13 May 2025 | tx 6+43,988 |
| Structure Therapeutics Inc. |
| 51,804 |
| reported |
| 23 Jun 2025 |
| tx 3+160,399 |
| AFFYMAX INC | 12,000 | reported | 13 Jun 2012 | tx 6+39,000 |
| KALOBIOS PHARMACEUTICALS INC | 5,000 | reported | 10 Jul 2015 | tx 3+40,000 |
| GILEAD SCIENCES, INC. | 4,884 | reported | 30 Apr 2026 | tx 8+32,821 |
| Oruka Therapeutics, Inc. | 3,500 | reported | 05 Feb 2010 | tx 19+1,875,307 |
| Jazz Pharmaceuticals plc | 1,527 | reported | 26 Feb 2026 | tx 1+1,527 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Apr 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 1,146 | 0.00 USD | |
| 30 Apr 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 4,884 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Jazz Pharmaceuticals plc | 1,527 | 0.00 USD | |
| 23 Jun 2025 | GRANT_AWARD | Structure Therapeutics Inc. | 51,804 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Royalty Pharma plc | 7,614 | 0.00 USD | |
| 07 May 2025 | GRANT_AWARD | GILEAD SCIENCES, INC. | 1,516 | 0.00 USD | |
| 07 May 2025 | GRANT_AWARD | GILEAD SCIENCES, INC. | 6,809 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Structure Therapeutics Inc. | 33,595 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Royalty Pharma plc | 9,293 | 0.00 USD | |
| 08 May 2024 | GRANT_AWARD | GILEAD SCIENCES, INC. | 2,310 | 0.00 USD | |
| 08 May 2024 | GRANT_AWARD | GILEAD SCIENCES, INC. | 12,648 | 0.00 USD | deriv |
| 02 Feb 2024 | GRANT_AWARD | GILEAD SCIENCES, INC. | 512 | 0.00 USD | |
| 02 Feb 2024 | GRANT_AWARD | GILEAD SCIENCES, INC. | 2,996 | 0.00 USD | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 4,255 | 229.00 USD | |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,462 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,676 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 4,460 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 2,044 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 449 | — | deriv |
| 03 Aug 2023 | GRANT_AWARD | Structure Therapeutics Inc. | 75,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | Royalty Pharma plc | 7,747 | 0.00 USD | |
| 31 May 2023 | GRANT_AWARD | SEATTLE GENETICS INC /WA | 2,044 | 0.00 USD | |
| 05 Oct 2022 | OTHER | Global Blood Therapeutics, Inc. | 2,500 | — | |
| 05 Oct 2022 | OTHER | Global Blood Therapeutics, Inc. | 2,500 | — | |
| 05 Oct 2022 | OTHER | Global Blood Therapeutics, Inc. | 119,650 | — |
3 purchases reported after at least 12 months of silence — most recent on 02 Feb 2017.